Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions

By A. Colombo, J. Drzewiecki, A. Banning, E. Grube, K. Hauptmann, S. Silber, D. Dudek, S. Fort, F. Schiele, K. Zmudka and 2 more. Circulation, 2003

1,090 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. (2005, result): “Of note, however, the absolute and relative efficacy of the paclitaxel-eluting stent in this trial were somewhat diminished compared with earlier studies in patients with less complex lesions.(3,4) However, the upper bound of the 30% observed relative reduction in the primary end point of target ves”
Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study* (2005, neutral): “Age, y 6310 6510 0.027 Male sex 98 (78) 98 (76) 0.85 Diabetes mellitus 39 ( 31 ) 41 (32) 0.99 Systemic hypertension 81 (64) 82 (64) 0.99 Hypercholesterolemia 88 (70) 80 (62) 0.24 Current smokers 20 (16) 20 (16) 0.93 Family history 26 (21) 19 (15) 0.28 Previous myocardial infarction 41 (33) 48 (37) 0”